Market Research Expert

Dermatological Diagnostics and Therapeutics Market: Growing Occurrence of Chronic Dermatological Diseases to Drive Market Growth

Press Release   •   Oct 04, 2016 07:58 EDT

A new market research report by Transparency Market Research, titled “Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Size, Share And Forecasts 2012 - 2018,” encapsulates an extensive analysis on the market for dermatology diagnostic devices and therapeutics. It also aids in understanding the top factors impacting the development of this market, both negatively and positively.

The key trends in the utilization pattern of numerous therapeutics and diagnostic devices for dermatology have also been presented. Tools including SWOT analysis and Porter’s five forces analysis have been employed in order to present an evaluation on the degree of competition in this market. The fundamental technological developments currently taking place or are bound to take place in the market have also been encapsulated. The top segments and sub-segments in the market and their predicted stated by the end of the forecast horizon also form an integral part of this report. Furthermore, information has also been deployed on the most lucrative region in the market. The report also delves into the particular product lines of the leading players in the market in order to provide a complete understanding of the overall market.

The rising geriatric population is a key factor driving the growth of the market. In addition, the patent expiration of key drugs have increased the competition in this market, thus positively impacting its growth. Furthermore, the growing occurrence of chronic dermatological diseases such as acne, psoriasis, rosacea, cell carcinoma, eczema, dermatitis, and pruritus will boost the growth of the global dermatology diagnostic devices and therapeutics market. Amongst these, acne has come up as the most common ailment and represent the highest share of 28.7% in the market. This segment is trailed by the segments of psoriasis, rosacea, and atopic dermatitis, respectively.

Download exclusive Sample of this Report:

The market is segmented in terms of diagnostic procedures, therapeutic procedures, and geography. On the basis of diagnostic procedures, the report categorizes the market into dermoscopy, skin biopsy, patch testing, culture, morbidity/prevalence, and phototests. By therapeutic procedure, the report segments the market into corticosteroids, anti-acne, anti-psoriasis, and topical and other dermatological drugs. Geographically, the report categorizes the market into Europe, North America, Asia Pacific, and Rest of the World (RoW).

Owing to the rising pressure, companies operating in the global dermatological diagnostics and therapeutics market are engaging into licensing agreements. This is done so as to increase their product portfolio and for improving their foothold in this market. AGI Dermatics, Chester Valley Pharmaceuticals Inc, Allergan Inc, Amgen Inc, Eisai Inc., Genentech Inc., Onset Therapeutics, Medicis Pharmaceutical Corp, Prime Pharmaceuticals Corp, Sinclair Pharmaceuticals, Summers Laboratories Inc, and Valeant Pharmaceuticals International, among others, are the prominent players dominant in the market.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,


NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453



Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.